Electromed Inc. | Income Statement

Fiscal year is July-June. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
15,104.40
15,347.90
19,176.40
22,992.00
25,861.10
28,697.60
Cost of Goods Sold (COGS) incl. D&A
4,655.40
4,853.90
5,690.20
5,098.70
5,292.70
5,841.60
Gross Income
10,449.10
10,494.00
13,486.20
17,893.30
20,568.40
22,856
SG&A Expense
12,276.40
11,382.60
11,792.00
14,749.00
16,866.10
19,843.40
EBIT
1,827.40
888.60
1,694.20
-
3,702.30
3,012.70
Unusual Expense
-
211.00
84.00
17.00
-
-
Non Operating Income/Expense
-
63.00
300.00
18.00
133.00
4.10
Interest Expense
133.60
91.40
88.00
79.50
66.90
-
Pretax Income
1,944.30
819.60
1,224.50
3,042.50
3,519.50
3,028.40
Income Tax
615.00
469.00
132.00
830.00
1,290.00
1,126
Consolidated Net Income
1,329.30
1,288.60
1,092.50
2,212.50
2,229.50
1,902.40
Net Income
1,329.30
1,288.60
1,092.50
2,212.50
2,229.50
1,902.40
Net Income After Extraordinaries
1,329.30
1,288.60
1,092.50
2,212.50
2,229.50
1,902.40
Net Income Available to Common
1,329.30
1,288.60
1,092.50
2,212.50
2,229.50
1,902.40
EPS (Basic)
0.16
0.16
0.13
0.27
0.26
0.22
Basic Shares Outstanding
8,114.30
8,114.30
8,115.60
8,135.50
8,168.20
8,207.40
EPS (Diluted)
0.16
0.16
0.13
0.27
0.26
0.22
Diluted Shares Outstanding
8,114.30
8,114.30
8,153.70
8,248.40
8,461.10
8,620.10
EBITDA
1,237.50
193.00
2,430.40
3,883.00
4,457.50
3,802.70
Non-Operating Interest Income
16.70
12.40
2.30
12.70
17.00
19.90

About Electromed

View Profile
Address
500 6th Avenue Northwest
New Prague Minnesota 56071
United States
Employees -
Website http://www.electromed.com
Updated 07/08/2019
Electromed, Inc. engages in the development, manufacture, marketing, and sale of innovative products that provide airway clearance therapy. It includes smartvest, airways clearance system, and related products to patients with compromised pulmonary function with a commitment to excellence and compassionate service. It focuses on building market awareness, and acceptance of its products and services with physicians, clinicians, patients, and third-party payers.